Plasma concentration based response surface model predict better than effect-site concentration based model for...

Area of Science:

• Pharmacology
• Anesthesiology
• Clinical Pharmacokinetics

Background:

• Procedural sedation for EGD and colonoscopy requires precise control of patient emergence.
• Midazolam and alfentanil are common sedatives, but their concentration-effect relationships for wake-up are not fully understood.
• Predicting patient wake-up time is crucial for efficient patient flow and safety.

Purpose of the Study:

• To develop and compare patient wake-up prediction models using plasma concentrations (Cp) and effect-site concentrations (Ce) of midazolam and alfentanil.
• To utilize response surface modeling, a pharmacodynamic tool, to assess drug interactions and predict emergence.
• To evaluate the accuracy of Cp- and Ce-based models in predicting true patient wake-up times.

Main Methods:

• Observer's Alertness/Sedation (OAA/S) scores monitored sedation depth.
• Pharmacokinetic simulation software calculated midazolam and alfentanil concentration pairs for Cp and Ce.
• Greco response surface models were constructed for Cp and Ce.
• Temporal analysis compared model-predicted wake-up times with actual patient wake-up times.

Main Results:

• Analysis included 33 patients undergoing EGD or colonoscopy.
• The Cp-based Greco model demonstrated significant synergy between midazolam and alfentanil.
• Cp-based model predicted wake-up time with a mean deviation of 1.0 ± 3.9 min.
• Ce-based model exhibited a significantly larger time deviation, exceeding 20 min.

Conclusions:

• Plasma concentration (Cp)-based models are more accurate for predicting patient wake-up after procedural sedation.
• Effect-site concentration (Ce)-based prediction is less reliable due to complex early drug distribution and non-steady-state conditions.
• These findings improve the understanding of midazolam and alfentanil pharmacodynamics for procedural sedation.